SLOAN HARRY — SEC Form 4 filings
SEC reporting owner CIK 1258248. 41 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 41 filings on record, filed 2024-02-14 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 4 filings — 438,415 shares, $3,416,211 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 250,000 shares, $9,537,500 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 74.
- Largest priced transaction: sale of 250,000 shares @ $38.15 ($9,537,500) in DraftKings Inc., filed 2024-06-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| DraftKings Inc. (DKNG) | Director | 21 | 2 legs · 125,000 sh · $2,942,500 | 1 leg · 250,000 sh · $9,537,500 | 46 |
| Ginkgo Bioworks Holdings, Inc. (DNA) | Director | 6 | 1 leg · 297,619 sh · $271,815 | — | 10 |
| STARZ ENTERTAINMENT CORP /CN/ (STRZ) | Director | 8 | 3 legs · 15,796 sh · $201,896 | — | 11 |
| Lionsgate Studios Corp. (LION) | Director | 5 | — | — | 7 |
| Lionsgate Studios Corp. (LION) | Director | 1 | — | — | — |
Form 4 filings — SLOAN HARRY
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Lionsgate Studios Corp. (LION) | Grant/award (A): 13,405 @ $0 · Grant/award (A): 5,362 @ $11.19 | EDGAR |
| 2026-08-06 | 4 | DraftKings Inc. (DKNG) | Grant/award (A): 10,588 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Grant/award (A): 25,000 (derivative) | EDGAR |
| 2026-05-14 | 4 | DraftKings Inc. (DKNG) | Option exercise (M): 5,562 · Option exercise (M): 5,562 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Lionsgate Studios Corp. (LION) | Grant/award (A): 6,828 @ $9.52 | EDGAR |
| 2026-02-18 | 4 | DraftKings Inc. (DKNG) | Purchase (P): 100,000 @ $21.85 | EDGAR |
| 2026-02-12 | 4 | DraftKings Inc. (DKNG) | Option exercise (M): 507 · Grant/award (A): 507 (derivative) @ $0 · Option exercise (M): 507 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | STARZ ENTERTAINMENT CORP /CN/ (STRZ) | Grant/award (A): 4,753 @ $10.52 | EDGAR |
| 2025-12-02 | 4 | Lionsgate Studios Corp. (LION) | Grant/award (A): 20,107 @ $0 · Grant/award (A): 8,723 @ $7.46 · Tax withholding (F): 0 @ $7.46 | EDGAR |
| 2025-11-12 | 4 | DraftKings Inc. (DKNG) | Purchase (P): 25,000 @ $30.30 | EDGAR |
| 2025-11-07 | 4 | DraftKings Inc. (DKNG) | Option exercise (M): 491 · Grant/award (A): 491 (derivative) @ $0 · Option exercise (M): 491 (derivative) @ $0 | EDGAR |
| 2025-09-15 | 4 | Lionsgate Studios Corp. (LION) | Holdings only — no transactions reported | EDGAR |
| 2025-08-21 | 4 | STARZ ENTERTAINMENT CORP /CN/ (STRZ) | Purchase (P): 6,614 @ $12.55 · Purchase (P): 1,082 @ $12.71 · Purchase (P): 8,100 @ $12.98 | EDGAR |
| 2025-08-07 | 4 | DraftKings Inc. (DKNG) | Option exercise (M): 305 · Grant/award (A): 305 (derivative) @ $0 · Option exercise (M): 305 (derivative) @ $0 · Grant/award (A): 5,562 (derivative) @ $0 | EDGAR |
| 2025-08-01 | 4 | STARZ ENTERTAINMENT CORP /CN/ (STRZ) | Grant/award (A): 1,112 @ $0 | EDGAR |
| 2025-06-13 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Option exercise (M): 10,822 · Option exercise (M): 10,822 (derivative) · Grant/award (A): 34,375 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | DraftKings Inc. (DKNG) | Gift (G): 100 @ $0 | EDGAR |
| 2025-05-21 | 4 | DraftKings Inc. (DKNG) | Option exercise (M): 6,969 · Option exercise (M): 6,969 (derivative) @ $0 | EDGAR |
| 2025-05-08 | 4 | Lionsgate Studios Corp. (LION) | Holdings only — no transactions reported | EDGAR |
| 2025-05-08 | 4 | STARZ ENTERTAINMENT CORP /CN/ (LGF.A) | Other (J): 72,324 @ $0 · Other (J): 277,113 @ $0 | EDGAR |
| 2025-05-08 | 4 | Lionsgate Studios Corp. (LION) | Other (J): 380,255 @ $0 | EDGAR |
| 2025-05-08 | 4 | STARZ ENTERTAINMENT CORP /CN/ (STRZ) | Other (J): 25,351 @ $0 | EDGAR |
| 2025-05-08 | 4 | DraftKings Inc. (DKNG) | Option exercise (M): 409 · Grant/award (A): 409 (derivative) @ $0 · Option exercise (M): 409 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | LIONS GATE ENTERTAINMENT CORP /CN/ (LGF.A) | Grant/award (A): 2,897 @ $8.63 · Grant/award (A): 3,238 @ $7.72 | EDGAR |
| 2025-02-21 | 4 | DraftKings Inc. (DKNG) | Gift (G): 100,000 @ $0 | EDGAR |
| 2025-02-13 | 4 | DraftKings Inc. (DKNG) | Option exercise (M): 316 · Grant/award (A): 316 (derivative) @ $0 · Option exercise (M): 316 (derivative) @ $0 | EDGAR |
| 2024-12-13 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Other (J): 235,780 | EDGAR |
| 2024-12-02 | 4 | LIONS GATE ENTERTAINMENT CORP /CN/ (LGF.A) | Grant/award (A): 3,034 @ $8.24 · Grant/award (A): 9,102 @ $0 · Grant/award (A): 3,392 @ $7.37 · Grant/award (A): 10,176 @ $0 | EDGAR |
| 2024-11-22 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Other (J): 4,222 | EDGAR |
| 2024-11-14 | 4 | DraftKings Inc. (DKNG) | Gift (G): 250,000 @ $0 | EDGAR |
| 2024-11-08 | 4 | DraftKings Inc. (DKNG) | Option exercise (M): 352 · Grant/award (A): 352 (derivative) @ $0 · Option exercise (M): 352 (derivative) @ $0 | EDGAR |
| 2024-09-16 | 4 | LIONS GATE ENTERTAINMENT CORP /CN/ (LGF.A) | Holdings only — no transactions reported | EDGAR |
| 2024-08-01 | 4 | DraftKings Inc. (DKNG) | Option exercise (M): 383 · Grant/award (A): 383 (derivative) @ $0 · Option exercise (M): 383 (derivative) @ $0 · Grant/award (A): 6,969 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | DraftKings Inc. (DKNG) | Gift (G): 500,000 @ $0 · Gift (G): 500,000 @ $0 · Sale (S): 250,000 @ $38.15 | EDGAR |
| 2024-06-14 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Option exercise (M): 105,263 · Option exercise (M): 105,263 (derivative) · Grant/award (A): 432,900 (derivative) @ $0 · Grant/award (A): 571,428 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | DraftKings Inc. (DKNG) | Option exercise (M): 6,339 · Option exercise (M): 6,339 (derivative) @ $0 | EDGAR |
| 2024-05-14 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Purchase (P): 297,619 @ $0.91 | EDGAR |
| 2024-05-02 | 4 | DraftKings Inc. (DKNG) | Option exercise (M): 330 · Grant/award (A): 330 (derivative) @ $0 · Option exercise (M): 330 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | DraftKings Inc. (DKNG) | Gift (G): 18,000 @ $0 · Gift (G): 25,000 @ $0 | EDGAR |
| 2024-02-21 | 4 | DraftKings Inc. (DKNG) | Option exercise (M): 929,099 · Tax withholding (F): 254,354 @ $42.01 · Option exercise (M): 929,099 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | DraftKings Inc. (DKNG) | Option exercise (M): 322 · Grant/award (A): 322 (derivative) @ $0 · Option exercise (M): 322 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1258248 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →